Globalization of business operations is one of the thrust areas of the group. The initiatives undertaken on this front have resulted in high growth of both exports of APIs and Speciality Chemicals. Focus on niche markets along with increased presence in the regulated markets will continue to remain as the Companys’ areas of priority.
ADL with its inherent strengths of timely responses, competitive pricing, firm commitments, has earned its reputation for being a dependable and reliable source of bulk actives and its intermediates in the international markets, enabling it to mark a definite global presence.
Products exported over 85 countries worldwide.
Enjoys a distinguished clientele of MNCs viz. Sanofi –Aventis , Merck, Teva , Searle, Pfizer, Bayer and Clariant – just to name a few.
Government Recognized Export House Status for past many years.
Financial Year 2006-2007 Export Turnover in excess of US$ 27 mns.s
The Company has already completed its validation batches for its premier products in new USFDA compliant facility & filed requisite data for USFDA for API production.
ADL has Drug Master Files in CTD format for almost whole Product range with another four under preparation.
The specialty chemicals plant of ADL is ISO 9002 certified.
The intermediate plant for the USFDA compliant facility is also ISO 9001 : 2000 certified.